Avenue Biosciences
A transatlantic biotechnology company specialising in novel protein engineering technologies
Avenue Biosciences has raised €7.2M across 2 funding rounds from 7 investors, most recently a Seed round in Jan 2026. Based in Helsinki, Finland; active in Healthtech. Data as of 28 Oct 2026.
Helsinki, Finlandwww.avenuebiosciences.com ↗
Total raised
€7.2M
€7,185,451
Funding rounds
2
Investors
7
distinct backers
Active since
2024-10
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDAvenue Biosciences — funding by year — interactive chart.
Data table
| Avenue Biosciences — funding by year | |
|---|---|
| 2024 | €2.3M |
| 2026 | €4.9M |
Signals
High confidenceRaise-next likelihood60
base rate 44% for Seed
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood14
base rate 11% (2+ rounds)
- ▼ Young (<3y)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-12 | Seed | €4.9M | Balnord,Dimerent,Inventure,Tesi,University of Helsinki,Voima Ventures | View deal → |
| 2024-10-22 | Seed | €2.3M | Angel Investors,Inventure,Voima Ventures | View deal → |
Investors
7Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData